Doctors Reveal Mounjaro Price to Soha Ali Khan After Aishwarya's Video
In the wake of comedian Aishwarya Mohanraj's honest 15-minute YouTube video detailing her use of Mounjaro for weight loss, Bollywood actor Soha Ali Khan championed open discussions on weight loss drugs like Mounjaro. Facing trolls and applause alike, Aishwarya's revelation prompted Soha to consult medical experts, highlighting the Mounjaro price in India, eligibility criteria, contraindications, and the critical role of medical supervision. This guide dives into their insights while providing essential context on GLP-1 medications for metabolic health.
The Spark: Aishwarya Mohanraj's Candid Revelation
Aishwarya Mohanraj shared her weight loss journey transparently, admitting she turned to Mounjaro—not just diet and exercise—after struggling to shed pounds. In her video, she noted each injection cost Rs 4,000 but emphasized, "I'm not recommending jack shit." This raw honesty divided social media: some trolled her, while others, like Soha Ali Khan, applauded her courage.
Soha posted on social media: "So finally someone said it. They lost a ton of weight not just by eating right or working out, but by taking Mounjaro. And I think it takes great courage to speak the truth." She added, "Injections can help, but they are serious, and they have side effects. They need tests and medical supervision. So instead of asking who is taking it, we should ask ourselves, who really needs it?"
Soha Ali Khan's Podcast: Expert Dialogue on Weight Loss Drugs
Rejecting half-baked influencer advice, Soha hosted a podcast with Dr. Ambrish Mithal, Group Chairman of Endocrinology and Diabetology at Max Healthcare, and Dr. Juhi Agarwal, a clinical nutritionist. They addressed Mounjaro weight loss drug cost, ideal candidates, those who should avoid it, side effects, and future pricing trends.
Current Pricing of Mounjaro and Similar Drugs
Aishwarya mentioned Rs 4,000 per jab, but experts clarified costs are monthly. Dr. Mithal stated, "I think the lower doses are Rs 12,000 a month. It has come down to almost Rs 10,000 now. The higher doses are around Rs 20,000 or Rs 22,000." Dr. Agarwal noted pricing shifted from per-injection (common a couple of years ago) to monthly packages: "You can say Rs 12,000 to Rs 20,000 per month is the current cost."
Dr. Mithal explained high prices reflect R&D investments by patent holders like Eli Lilly (Mounjaro's maker). He predicted declines as hype builds and generics emerge: "It is a matter of time before drug prices fall once enough hype has been created around them, and more and more pharma companies start producing them." For context, similar GLP-1 drugs like Ozempic follow suit, though Mounjaro (tirzepatide) often commands a premium due to its dual-action mechanism.
Who Is Eligible for Weight Loss Drugs Like Mounjaro?
Not for casual weight loss, these drugs target those where obesity exacerbates health issues. Dr. Mithal outlined: "Those who have associated conditions, where losing weight will get rid of that condition or help control it much better, are clearly candidates." Examples include fatty liver, diabetes, or pre-diabetes, where shedding kilograms eases bodily stress.
Key BMI thresholds:
- BMI of 27+ with comorbidities (e.g., hypertension, dyslipidemia)
- BMI of 30+ without comorbidities (obesity class I/II)
- BMI over 40-50: Drugs work, but bariatric surgery may be recommended alongside, as it alters the stomach and small intestine for severe obesity.
Patients should discuss with endocrinologists; lifestyle changes remain foundational.
Who Should Avoid Mounjaro and GLP-1 Weight Loss Drugs?
Safety first: Certain groups face heightened risks. Dr. Mithal listed contraindications:
